SI
WST icon

Stephens Inc’s West Pharmaceutical WST Stock Holding History

Stephens Inc’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-973
Closed -$320K – 1345
2024
Q2 		$320K Sell
973
-111
-10% -$39.2K ﹤0.01% 979
2024
Q1 		$429K Buy
1,084
+5
+0.5% +$1.85K 0.01% 875
2023
Q4 		$380K Buy
1,079
+326
+43% +$115K 0.01% 847
2023
Q3 		$283K Sell
753
-357
-32% -$138K 0.01% 921
2023
Q2 		$425K Sell
1,110
-10
-0.9% -$3.57K 0.01% 798
2023
Q1 		$388K Buy
1,120
+24
+2% +$7.01K 0.01% 791
2022
Q4 		$258K Sell
1,096
-889
-45% -$211K 0.01% 908
2022
Q3 		$488K Buy
1,985
+43
+2% +$13.1K 0.01% 715
2022
Q2 		$587K Sell
1,942
-80
-4% -$26K 0.01% 677
2022
Q1 		$830K Buy
2,022
+398
+25% +$156K 0.01% 641
2021
Q4 		$762K Sell
1,624
-586
-27% -$252K 0.01% 719
2021
Q3 		$938K Sell
2,210
-149
-6% -$62.8K 0.01% 667
2021
Q2 		$847K Buy
2,359
+103
+5% +$34K 0.01% 720
2021
Q1 		$636K Buy
+2,256
New +$646K 0.01% 765
2020
Q4 		– Sell
-1,017
Closed -$279K – 1273
2020
Q3 		$279K Buy
1,017
+9
+0.9% +$2.38K 0.01% 910
2020
Q2 		$229K Sell
1,008
-534
-35% -$105K ﹤0.01% 927
2020
Q1 		$235K Sell
1,542
-68
-4% -$10.5K 0.01% 840
2019
Q4 		$242K Sell
1,610
-1,721
-52% -$251K 0.01% 951
2019
Q3 		$472K Buy
3,331
+25
+0.8% +$3.44K 0.01% 769
2019
Q2 		$414K Buy
3,306
+96
+3% +$11.3K 0.01% 803
2019
Q1 		$354K Buy
3,210
+383
+14% +$39.8K 0.01% 860
2018
Q4 		$277K Buy
2,827
+46
+2% +$4.99K 0.01% 878
2018
Q3 		$343K Buy
2,781
+240
+9% +$26.9K 0.01% 898
2018
Q2 		$252K Hold
2,541
– – 0.01% 749
2018
Q1 		$224K Buy
2,541
+283
+13% +$26.5K 0.01% 629
2017
Q4 		$223K Buy
2,258
+72
+3% +$7.06K 0.01% 620
2017
Q3 		$210K Buy
+2,186
New +$198K 0.01% 657

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Stephens Inc's WST Position: Q3 2024 in Review

Stephens Inc sold out of West Pharmaceutical (WST) in Q3 2024, closing a stake of 973 shares — an estimated $320K sold.

Stephens Inc first reported a position in WST in Q3 2017 and held it in 27 quarters. The position peaked at $938K in Q3 2021. 730 funds tracked by Wall St. Rank hold WST as of Q3 2024.

  • Stephens Inc reported no remaining West Pharmaceutical position as of Q3 2024 after selling out during the quarter.
  • Stephens Inc sold 973 West Pharmaceutical shares in Q3 2024, an estimated $320K.
  • Stephens Inc first reported a position in West Pharmaceutical in Q3 2017 and held it in 27 quarters.
  • Stephens Inc's West Pharmaceutical position peaked at $938K in Q3 2021.
  • 730 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2024.

Based on Stephens Inc's 13F filing for Q3 2024, filed 28 Oct 2024.